Board Chair Emeritus
Managing Partner, Deerfield Management Company, LP

Jim Flynn, MS, is the Managing Partner of Deerfield. He joined Deerfield in 2000 and is responsible for the management of the Firm. Under his leadership, Deerfield has built deep healthcare information expertise through Deerfield Intelligence; expanded its investment capabilities to include venture and private structured financings; established the Deerfield Foundation to contribute toward the health and welfare of
disadvantaged children; created Deerfield Discovery and Development, LLC, which organizes Deerfield’s discovery research efforts; and founded Cure, a healthcare innovation center at 345 Park Avenue South in New York City.

Before joining Deerfield, Jim was an analyst at Furman Selz, covering pharmaceutical and medical device companies. Prior to that, he served as Vice President of Corporate Development of Alpharma Inc., a pharmaceutical company, where his responsibilities included business development and strategic planning, and the management of licensing transactions. Jim began his career in healthcare investing at Kidder, Peabody & Co., where he ultimately served as a senior analyst covering the specialty pharmaceutical industry.

Jim holds a BS in Cellular and Molecular Biology and Economics from the University of Michigan and a MS in Biotechnology from Johns Hopkins University.